PAV-220830FLY-599

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-599

3919-190624

NHP-220830FLY-1

anti-cd4 infusion premed. , pre-dosing vitals; HR 130, RR 36, T 99. Interim vitals; HR 150, RR 40, T 98.8. End of infusion vitals; HR 160, RR 40, T 99.1. No adverse reactions. , anti-cd4 infusion

https://fairdomhub.org/sops/795

Treatment

Not specified

Flynn Lab

2019-06-24 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

365(35milliliter)

milligram

Diphenhydramine

Medication

Intramuscularly

8

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 11

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:36

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH